World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
63
Citations
19615
World Ranking
10027
National Ranking
4389

Overview

Michelle A. Kelliher is affiliated with the University of Massachusetts Chan Medical School in the United States. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, Medicine, and Immunology and Microbiology. Within these areas, their work covers several subfields including Molecular Biology, Immunology, Public Health, Environmental and Occupational Health, Hematology, and Oncology.

Their research topics include Acute Lymphoblastic Leukemia research, interferon and immune responses, cell death mechanisms and regulation, RNA modifications and cancer, RNA regulation and disease, NF-κB signaling pathways, and chronic myeloid leukemia treatments.

Frequently publishing in specialized venues, Kelliher's work appears often in Blood, Proceedings of the National Academy of Sciences, Cell Reports, Leukemia, and bioRxiv (Cold Spring Harbor Laboratory).

Selected recent papers authored or co-authored by Kelliher include:

  • Sequential activation of necroptosis and apoptosis cooperates to mediate vascular and neural pathology in stroke, 2020, Proceedings of the National Academy of Sciences
  • Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia, 2022, Blood
  • T cell-derived tumor necrosis factor induces cytotoxicity by activating RIPK1-dependent target cell death, 2021, JCI Insight
  • ESRRB regulates glucocorticoid gene expression in mice and patients with acute lymphoblastic leukemia, 2020, PubMed
  • Prostaglandin E2 stimulates cAMP signaling and resensitizes human leukemia cells to glucocorticoid-induced cell death, 2020, Blood

Kelliher frequently collaborates with researchers such as Lihua Julie Zhu, Kayleigh Gallagher, Michael R. Green, Kevin W. O'Connor, and Alok Mishra, among others.

Best Publications

  • The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal

    Michelle A Kelliher;Stefan Grimm;Yasumasa Ishida;Frank Kuo

  • RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation.

    Etienne Meylan;Kim Burns;Kay Hofmann;Vincent Blancheteau

  • Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell death.

    Pontus Orning;Pontus Orning;Dan Weng;Dan Weng;Kristian Starheim;Kristian Starheim;Dmitry Ratner

  • Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL

    Michelle A. Kelliher;Jami McLaughlin;Owen N. Witte;Naomi Rosenberg

  • RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer

    Andrew L Wolfe;Kamini Singh;Yi Zhong;Philipp Drewe

  • The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation.

    Anne Devin;Amy Cook;Yong Lin;Yolanda Rodriguez

  • RIPK1 Blocks Early Postnatal Lethality Mediated by Caspase-8 and RIPK3

    Christopher P. Dillon;Ricardo Weinlich;Diego A. Rodriguez;James G. Cripps

  • RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis

    Marius Dannappel;Katerina Vlantis;Snehlata Kumari;Apostolos Polykratis

  • RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS.

    Yasushi Ito;Dimitry Ofengeim;Ayaz Najafov;Sudeshna Das

  • Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-{kappa}B activation but does not contribute to interferon regulatory factor 3 activation.

    Nicole Cusson-Hermance;Smriti Khurana;Thomas H. Lee;Katherine A. Fitzgerald

  • An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.

    Birgit Knoechel;Justine E Roderick;Kaylyn E Williamson;Jiang Zhu

  • BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment.

    Georg E. Winter;Georg E. Winter;Andreas Mayer;Dennis L. Buckley;Michael A. Erb

  • Core Transcriptional Regulatory Circuit Controlled by the TAL1 Complex in Human T Cell Acute Lymphoblastic Leukemia

    Takaomi Sanda;Lee N. Lawton;M. Inmaculada Barrasa;Zi Peng Fan

  • Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha.

    M A Kelliher;D C Seldin;P Leder

  • Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc

    Vishva Mitra Sharma;Jennifer Ann Calvo;Kyle M. Draheim;Leslie A. Cunningham

  • NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis.

    Amit K. Pandey;Yibin Yang;Zhaozhao Jiang;Sarah Merritt Fortune

  • Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death

    Dan Weng;Robyn Lynn Marty-Roix;Sandhya Ganesan;Megan K. Proulx

  • The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

    Elizabeth C. Townsend;Mark A. Murakami;Alexandra Christodoulou;Amanda L. Christie

  • RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease

    Dimitry Ofengeim;Sonia Mazzitelli;Yasushi Ito;Judy Park DeWitt

  • The kinase activity of Rip1 is not required for tumor necrosis factor-alpha-induced IkappaB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2.

    Thomas H. Lee;Jennifer Shank;Nicole Cusson;Michelle A. Kelliher

Frequent Co-Authors

Manolis Pasparakis
Manolis Pasparakis University of Cologne
A. Thomas Look
A. Thomas Look Harvard University
Lewis B. Silverman
Lewis B. Silverman Harvard University
Stephen E. Sallan
Stephen E. Sallan Harvard University
James E. Bradner
James E. Bradner Amgen (United States)
Jon C. Aster
Jon C. Aster Harvard Medical School
Katherine A. Fitzgerald
Katherine A. Fitzgerald University of Massachusetts Chan Medical School
John Bertin
John Bertin GlaxoSmithKline (United Kingdom)
Donna Neuberg
Donna Neuberg Harvard University
Andrew L. Kung
Andrew L. Kung Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Earning a degree in Biology or Biochemistry can be just the beginning of a diverse range of healthcare careers. Many students interested in biological sciences also explore related online degrees to enhance their expertise or shift into specialized fields.

For those seeking career advancement in nursing, exploring the easiest rn to bsn program options online can be a strategic move. Professionals looking to step into healthcare leadership roles may consider an online masters in healthcare management to open doors to executive opportunities.

The mental health sector is also growing, with many biology graduates pursuing psych np programs to become psychiatric nurse practitioners. Alternatively, if holistic health and nutrition spark your interest, a holistic nutrition degree can help you build a career in preventive health and wellness.

These online programs allow for flexible study while opening multiple pathways in the evolving healthcare landscape, making them excellent complementary options for students in Biology and Biochemistry.

Best Scientists Citing Michelle A. Kelliher

Trending Scientists

Recently Published Articles